Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis
暂无分享,去创建一个
N. Tanaka | Takefumi Kimura | H. Kitabatake | Naoyuki Fujimori | M. Komatsu | T. Umemura | K. Sano | E. Tanaka | Tomohiro Sekiguchi | A. Matsumoto | S. Shibata | Tomoo Yamazaki | Yuki Ichikawa | Soichiro Shibata
[1] Z. Goodman,et al. Epidemiology and natural history of non-alcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.
[2] Q. Pan,et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[3] F. Gonzalez,et al. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. , 2015, Biochimica et biophysica acta.
[4] K. Yoshioka,et al. Measurement of liver stiffness as a non‐invasive method for diagnosis of non‐alcoholic fatty liver disease , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[5] Katsutoshi Tokushige,et al. Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[6] A. Dhawan,et al. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. , 2014, World journal of gastroenterology.
[7] Nik Raihan Nik Mustapha,et al. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Journal of gastroenterology and hepatology.
[8] H. Cao,et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. , 2014, World journal of gastroenterology.
[9] Yoshito Itoh,et al. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2014, World journal of gastroenterology.
[10] S. Ahn,et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[11] M. Yoneda. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.
[12] A. Pollett,et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[13] J. Vergniol,et al. Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[14] Jonathan C. Cohen,et al. Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.
[15] T. Aoyama,et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy , 2011, Journal of Gastroenterology.
[16] O. Cummings,et al. Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease , 2011, Journal of clinical gastroenterology.
[17] Tomoko Nishizawa,et al. Down-regulation of Srebp-1c Is Associated with the Development of Burned-out Nash Running Title: Down-regulation of Srebp-1c with Nafld Progression , 2022 .
[18] M. Kadoya,et al. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.
[19] T. Aoyama,et al. Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels , 2010, Journal of clinical gastroenterology.
[20] T. Saheki,et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[21] T. Aoyama,et al. Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case , 2008, Clinical journal of gastroenterology.
[22] Laurent Castera,et al. Non-invasive evaluation of liver fibrosis using transient elastography. , 2008, Journal of hepatology.
[23] V. de Lédinghen,et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations , 2006, European journal of gastroenterology & hepatology.
[24] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[25] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[26] F. Brunello,et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. , 2011, Journal of hepatology.
[27] E. Oda. New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[28] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.